Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Macrophage-enriched Sectm1a promotes efficient efferocytosis to attenuate ischemia/reperfusion-induced cardiac injury
Xiaohong Wang, … , Wei Huang, Guo-Chang Fan
Xiaohong Wang, … , Wei Huang, Guo-Chang Fan
Published March 8, 2024
Citation Information: JCI Insight. 2024;9(5):e173832. https://doi.org/10.1172/jci.insight.173832.
View: Text | PDF
Research Article Cardiology Immunology

Macrophage-enriched Sectm1a promotes efficient efferocytosis to attenuate ischemia/reperfusion-induced cardiac injury

  • Text
  • PDF
Abstract

Efficient clearance and degradation of apoptotic cardiomyocytes by macrophages (collectively termed efferocytosis) is critical for inflammation resolution and restoration of cardiac function after myocardial ischemia/reperfusion (I/R). Here, we define secreted and transmembrane protein 1a (Sectm1a), a cardiac macrophage–enriched gene, as a modulator of macrophage efferocytosis in I/R-injured hearts. Upon myocardial I/R, Sectm1a-KO mice exhibited impaired macrophage efferocytosis, leading to massive accumulation of apoptotic cardiomyocytes, cardiac inflammation, fibrosis, and consequently, exaggerated cardiac dysfunction. By contrast, therapeutic administration of recombinant SECTM1A protein significantly enhanced macrophage efferocytosis and improved cardiac function. Mechanistically, SECTM1A could elicit autocrine effects on the activation of glucocorticoid-induced TNF receptor (GITR) at the surface of macrophages, leading to the upregulation of liver X receptor α (LXRα) and its downstream efferocytosis-related genes and lysosomal enzyme genes. Our study suggests that Sectm1a-mediated activation of the Gitr/LXRα axis could be a promising approach to enhance macrophage efferocytosis for the treatment of myocardial I/R injury.

Authors

Xiaohong Wang, Wa Du, Yutian Li, Hui-Hui Yang, Yu Zhang, Rubab Akbar, Hannah Morgan, Tianqing Peng, Jing Chen, Sakthivel Sadayappan, Yueh-Chiang Hu, Yanbo Fan, Wei Huang, Guo-Chang Fan

×

Figure 6

Gene expression profile analysis of KO and WT macrophages.

Options: View larger image (or click on image) Download as PowerPoint
Gene expression profile analysis of KO and WT macrophages.
(A) Volcano p...
(A) Volcano plot of differential gene expression identified by RNA-Seq in KO macrophages relative to WT controls. The x axis represents the log2 fold-change, and the y axis represents the –log10 P value. The significant genes are depicted in red, indicating that they exhibit both a P value (–log10) < 10–4 and an absolute log2 fold-change > 0.6. (B–E) Gene set enrichment analysis (GSEA) plots and heatmaps for efferocytosis-related gene sets in WT macrophages compared with KO macrophages. Enriched efferocytosis-related Gene Ontology (GO) terms in genes repressed in KO macrophages, including (B) positively regulated phagocytosis, (C) phagocytosis engulfment, (D) apoptotic cell clearance, and (E) lysosome lumen. Green curves indicate enrichment scores. The normalized enrichment score (NES), false discovery rate (FDR) q value, and FWER P value are indicated within each graph. NES > 1.1 and P < 0.05 were considered statistically significant. Representative genes were listed in the heatmap of each enrichment plot. Green and red color indicate down- versus upregulated genes, respectively. The genes written in red beside each heatmap are known to be controlled by LXRα. (F and G) RT-qPCR analysis validates that these efferocytosis-related genes are downregulated in KO macrophages but are upregulated by stimulation with GW3965, an agonist of LXRα (n = 3; *, P < 0.05). Expression of β-actin was used as the internal control for RT-qPCR. (H) Flow cytometry assay showing that the impaired efferocytosis in KO macrophages can be rescued by GW3965 treatment (n = 5; *, P < 0.05). All data are presented as mean ± SEM and analyzed by 2-way ANOVA (F and H).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts